Cas9 vs aixbt
aixbt (AIXBT) is 250.2× the size of Cas9 (CRISPR) by market capitalisation.
- Size ratio
- 1 : 250.2
CRISPR 0.4%Share of the two combined market caps99.6% AIXBT
Performance
CRISPRAIXBT
- 7 daysCRISPR
- 30 days—
- 90 days—
- 1 year—
Risk & extremes
| Metric | CRISPR | AIXBT |
|---|---|---|
| Max drawdown (400d) | -16.1% | -84.5% |
| Risk-adjusted return (90d) | — | -0.07 |
| Best 30 days (past year) | — | +62.1% |
| Worst 30 days (past year) | — | -52.0% |
Relative strength over 90 days: CRISPR outperformed AIXBT by 20.3% — measured on the CRISPR/AIXBT ratio, so it holds regardless of market direction.